Antimicrobial Resistance in ESKAPE Pathogens
By David M. P. De Oliveira, B. Forde, T. Kidd, P. Harris, M. Schembri, Scott A. Beatson, David L. Paterson, M. Walker. Clinical Microbiology Reviews, 2020
1,546 citations recorded by the source corpus.
Antimicrobial-resistant ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance. SUMMARY Antimicrobial-resistant ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance. This looming health threat has restimulated interest in the development of new antimicrobial therapies, has demanded the need for better patient care, and has facilitated heightened governance over stewardship practices.
Subfields: Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/c81d3e4f18beeab13a1bc0a90fc980463c40be48
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Medicine
Citations in the corpus
- ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics (2024, positive): “Recent reviews have provided an in-depth discussion of the mechanisms of resistance among ESKAPE pathogens to most traditional anti-microbial classes 5 .”
- Bacterial Antibiotic Resistance: The Most Critical Pathogens (2021, background): “aerogenes has also emerged, displaying resistance to the last-resort antibiotic colistin [7].”
- Identification of antimicrobial peptides from the human gut microbiome using deep learning (2022, methodology): “We set three experimental groups to test c_AMP antibacterial activity: (1) blank control group, 200 μl of LB solution; (2) bacterial control group, 100 μl of LB solution and 100 μl of bacterial solution; and (3) low-c_AMPs group (60 μmol L−1), 100 μl of LB solution, 95 μl of bacterial solution and 5”